Comparison of efficacy and tolerability of adjuvant therapy for resected high-risk stage III-IV cutaneous melanoma: a systemic review and Bayesian network meta-analysis

BACKGROUND: Although immune checkpoint inhibitors (ICIs) and targeted therapies have been widely used as adjuvant treatment for resected melanoma, the optimal therapy remains controversial. Therefore, we conducted this updated network meta-analysis (NMA) to assess the efficacy and tolerability of ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Ba, He, Zhu, Fangyuan, Zhang, Xiaoze, Mei, Zubing, Zhu, Yaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893404/
https://www.ncbi.nlm.nih.gov/pubmed/36743526
http://dx.doi.org/10.1177/17588359221148918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893404/
https://www.ncbi.nlm.nih.gov/pubmed/36743526
http://dx.doi.org/10.1177/17588359221148918

Ejemplares similares